MyFinsight
Home
Blog
About
Proceeds from the
issuance of shares, net of...
$27,874,441
Total cash flow from
financing activities
$27,874,441
Increase (decrease) in
cash and cash...
$4,166,209
Canceled cashflow
$23,708,232
Share-based compensation
$718,063
Increase in accrued
expenses and other...
$227,201
Share of loss on equity
investment
-$126,296
Depreciation
$52,032
Decrease in accounts
payable
$45,522
Amortization
$7,635
Proceeds from short-term
investments
$7,372,473
Total cash flow from
operating activities
-$14,987,656
Total cash flow from
investing activities
-$8,720,576
Canceled cashflow
$1,176,749
Canceled cashflow
$7,372,473
Net loss for the
period
-$14,533,948
Increase (decrease) in
amounts receivable and...
-$1,103,891
Purchase of short-term
investments
$15,781,000
Change in fair value of
the warrant...
-$335,019
Financial income, net
$143,204
Unrealized gain on
investment
$48,343
Equity investment in bc
therapeutics
$185,000
Purchase of equipment
$127,049
Back
Back
Cash Flow
BriaCell Therapeutics Corp. (BCTXZ)
BriaCell Therapeutics Corp. (BCTXZ)
source: myfinsight.com